Justin B Echouffo-Tcheugui1, Natalie Daya2, Chiadi E Ndumele3, Kunihiro Matsushita2,3, Ron C Hoogeveen4, Christie M Ballantyne4, Josef Coresh2, Amil M Shah5, Elizabeth Selvin2. 1. Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA. jechouf1@jhmi.edu. 2. Department of Epidemiology and Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. 3. Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA. 4. Section of Cardiovascular Research, Baylor College of Medicine and Houston Methodist DeBakey Heart & Vascular Center, Houston, TX, USA. 5. Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Abstract
AIMS/HYPOTHESIS: Elevated circulating growth differentiation factor-15 (GDF-15), a marker of cellular stress, is associated with both heart failure (HF) and diabetes. However, it is unclear to what extent GDF-15 is associated with HF among individuals with and without diabetes. METHODS: We evaluated 10,570 participants free of HF at Visit 3 (1993-1995) of the Atherosclerosis Risk in Communities study. We used Cox regression to evaluate the joint associations of GDF-15 and diabetes with incident HF. Models were adjusted for traditional cardiovascular risk factors. RESULTS: Among a total of 10,570 individuals (mean age of 60.0 years, 54% women, 27% black adults), elevated GDF-15 (≥75th percentile) was more common in people with diabetes compared with those without diabetes (32.8% vs 23.6%, p<0.0001). During 23 years of follow-up, there were 2429 incident HF events. GDF-15 (in quartiles) was independently associated with HF among those with and without diabetes, with a stronger association among individuals with diabetes (p-for-diabetes-GDF-15 interaction = 0.034): HR for highest vs lowest GDF-15 quartile (reference): 1.64 (95% CI 1.41, 1.91) among those without diabetes and 1.72 (95% CI 1.32, 2.23) among those with diabetes. Individuals with diabetes and elevated GDF-15 had the highest risk of incident HF (HR 2.46; 95% CI 1.99, 3.03). After accounting for HF risk factors, GDF-15 provided additional prognostic information among participants with diabetes (ΔC statistic for model with vs model without GDF-15: +0.008, p = 0.001) and among those without diabetes (+0.006, p<0.0001). CONCLUSIONS/ INTERPRETATION: In a community-based sample of US adults, GDF-15 provided complementary prognostic information on the HF risk, especially among individuals with diabetes.
AIMS/HYPOTHESIS: Elevated circulating growth differentiation factor-15 (GDF-15), a marker of cellular stress, is associated with both heart failure (HF) and diabetes. However, it is unclear to what extent GDF-15 is associated with HF among individuals with and without diabetes. METHODS: We evaluated 10,570 participants free of HF at Visit 3 (1993-1995) of the Atherosclerosis Risk in Communities study. We used Cox regression to evaluate the joint associations of GDF-15 and diabetes with incident HF. Models were adjusted for traditional cardiovascular risk factors. RESULTS: Among a total of 10,570 individuals (mean age of 60.0 years, 54% women, 27% black adults), elevated GDF-15 (≥75th percentile) was more common in people with diabetes compared with those without diabetes (32.8% vs 23.6%, p<0.0001). During 23 years of follow-up, there were 2429 incident HF events. GDF-15 (in quartiles) was independently associated with HF among those with and without diabetes, with a stronger association among individuals with diabetes (p-for-diabetes-GDF-15 interaction = 0.034): HR for highest vs lowest GDF-15 quartile (reference): 1.64 (95% CI 1.41, 1.91) among those without diabetes and 1.72 (95% CI 1.32, 2.23) among those with diabetes. Individuals with diabetes and elevated GDF-15 had the highest risk of incident HF (HR 2.46; 95% CI 1.99, 3.03). After accounting for HF risk factors, GDF-15 provided additional prognostic information among participants with diabetes (ΔC statistic for model with vs model without GDF-15: +0.008, p = 0.001) and among those without diabetes (+0.006, p<0.0001). CONCLUSIONS/ INTERPRETATION: In a community-based sample of US adults, GDF-15 provided complementary prognostic information on the HF risk, especially among individuals with diabetes.
Authors: M R Bootcov; A R Bauskin; S M Valenzuela; A G Moore; M Bansal; X Y He; H P Zhang; M Donnellan; S Mahler; K Pryor; B J Walsh; R C Nicholson; W D Fairlie; S B Por; J M Robbins; S N Breit Journal: Proc Natl Acad Sci U S A Date: 1997-10-14 Impact factor: 11.205
Authors: Peter Ganz; Bettina Heidecker; Kristian Hveem; Christian Jonasson; Shintaro Kato; Mark R Segal; David G Sterling; Stephen A Williams Journal: JAMA Date: 2016-06-21 Impact factor: 56.272
Authors: Christy L Avery; Laura R Loehr; Christopher Baggett; Patricia P Chang; Anna M Kucharska-Newton; Kunihiro Matsushita; Wayne D Rosamond; Gerardo Heiss Journal: J Am Coll Cardiol Date: 2012-09-26 Impact factor: 24.094
Authors: Daniel Schlittenhardt; Andreas Schober; Jens Strelau; Gabriel A Bonaterra; Walther Schmiedt; Klaus Unsicker; Jürgen Metz; Ralf Kinscherf Journal: Cell Tissue Res Date: 2004-10-01 Impact factor: 5.249
Authors: Gad Cotter; Adriaan A Voors; Margaret F Prescott; G Michael Felker; Gerasimos Filippatos; Barry H Greenberg; Peter S Pang; Piotr Ponikowski; Olga Milo; Tsushung A Hua; Min Qian; Thomas M Severin; John R Teerlink; Marco Metra; Beth A Davison Journal: Eur J Heart Fail Date: 2015-09-03 Impact factor: 15.534
Authors: Faiez Zannad; João Pedro Ferreira; Stuart J Pocock; Stefan D Anker; Javed Butler; Gerasimos Filippatos; Martina Brueckmann; Anne Pernille Ofstad; Egon Pfarr; Waheed Jamal; Milton Packer Journal: Lancet Date: 2020-08-30 Impact factor: 79.321
Authors: Anthony P Coll; Naveed Sattar; David B Savage; Bernard B Allan; Stephen O'Rahilly; Michael Chen; Pranali Taskar; Debra Rimmington; Satish Patel; John A Tadross; Irene Cimino; Ming Yang; Paul Welsh; Samuel Virtue; Deborah A Goldspink; Emily L Miedzybrodzka; Adam R Konopka; Raul Ruiz Esponda; Jeffrey T-J Huang; Y C Loraine Tung; Sergio Rodriguez-Cuenca; Rute A Tomaz; Heather P Harding; Audrey Melvin; Giles S H Yeo; David Preiss; Antonio Vidal-Puig; Ludovic Vallier; K Sreekumaran Nair; Nicholas J Wareham; David Ron; Fiona M Gribble; Frank Reimann Journal: Nature Date: 2019-12-25 Impact factor: 49.962
Authors: Katrina L Piercy; Richard P Troiano; Rachel M Ballard; Susan A Carlson; Janet E Fulton; Deborah A Galuska; Stephanie M George; Richard D Olson Journal: JAMA Date: 2018-11-20 Impact factor: 157.335
Authors: Mark V Pinti; Garrett K Fink; Quincy A Hathaway; Andrya J Durr; Amina Kunovac; John M Hollander Journal: Am J Physiol Endocrinol Metab Date: 2019-01-02 Impact factor: 4.310